Pharmaceutical

STAT+: Pharmalittle: White House drug-shortage task for...

A new White House task force on drug shortages brainstormed policies for stemmin...

Opinion: The high out-of-pocket cost of donating a kidney

New York state recently passed a law reimbursing kidney donors. The federal gove...

STAT+: Medicare slashes safety net hospital payments on...

Safety net hospitals are getting almost $1 billion less next year to offset the ...

STAT+: For brain-computer interfaces, the commercial hu...

Brain-computer interfaces hold promise for paralysis, but the business challenge...

Mesoblast plans new GvHD trial after another FDA rejection

Mesoblast plans follows an FDA response to the BLA resubmission for remestemcel-...

Evox Therapeutics teams with New York medical school to...

Evox and the Icahn School of Medicine will develop gene delivery vectors for car...

Accord gears up to commercialise Hipra’s Covid-19 vacci...

Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently...

Cellectis to focus on CAR-T cell therapies in 2023

Cellectis provided updates for the three CAR-T cell therapies trials, with the t...

Gilead reports 8.45% dip in net income for Q2 2023

Gilead Sciences has posted net income of $1.03bn in Q2 of 2023 compared with $1....

Bangladesh and the dengue vaccine question

Amid one of the worst dengue fever outbreaks in decades, Bangladesh has recorded...

BlueRock and bit.bio link to develop regulatory T cell-...

BlueRock Therapeutics signed an agreement with bit.bio to discover and manufactu...

US FDA approves Merck’s Ebola vaccine for under-18s

The US FDA has granted approval for an expanded indication of Merck’s Ebola vacc...

Tweets of the week: Purdue bankruptcy, HIV prevention a...

This week, people are tweeting about Purdue's ongoing bankruptcy case, pandemic ...

Opinion: Former Sen. Max Baucus: Breakthrough Alzheimer...

Former Sen. Max Baucus: We must continue to forge a path to swift, affordable co...

Opinion: Without a plan to fight superbugs, the Cancer ...

Antimicrobial resistance is a threat to everyone. But cancer patients are partic...